Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer

B A Leone, M J Langhi, M R Machiavelli, M R Barbieri, L A Romero Acuña, C T Vallejo, M E Domínguez, J E Pérez, J A Lacava, R Rodríguez, J M Romero Acuña, S Amato, A O Romero, E H Ortiz, Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. The cancer journal from Scientific American. ,vol. 4, pp. 125- 131 ,(1998)

Marco Colleoni, Marco Bonetti, Alan S. Coates, Monica Castiglione-Gertsch, Richard D. Gelber, Karen Price, Carl-Magnus Rudenstam, Jurij Lindtner, John Collins, Beat Thürlimann, Stig Holmberg, Andrea Veronesi, Giovanni Marini, Aron Goldhirsch, , Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen Receptors Journal of Clinical Oncology. ,vol. 18, pp. 584- 590 ,(2000) , 10.1200/JCO.2000.18.3.584

L G Fulford, D F Easton, J S Reis-Filho, A Sofronis, C E Gillett, S R Lakhani, A Hanby, Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology. ,vol. 49, pp. 22- 34 ,(2006) , 10.1111/J.1365-2559.2006.02453.X

Emad A. Rakha, Maysa E. El-Sayed, Andrew R. Green, Andrew H. S. Lee, John F. Robertson, Ian O. Ellis, Prognostic markers in triple-negative breast cancer Cancer. ,vol. 109, pp. 25- 32 ,(2007) , 10.1002/CNCR.22381

Nancy U. Lin, Elizabeth Claus, Jessica Sohl, Abdul R. Razzak, Amal Arnaout, Eric P. Winer, Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer Cancer. ,vol. 113, pp. 2638- 2645 ,(2008) , 10.1002/CNCR.23930

Dalia M. Abd El-Rehim, Graham Ball, Sarah E. Pinder, Emad Rakha, Claire Paish, John F.R. Robertson, Douglas Macmillan, Roger W. Blamey, Ian O. Ellis, High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses International Journal of Cancer. ,vol. 116, pp. 340- 350 ,(2005) , 10.1002/IJC.21004

Priya Rastogi, Stewart J Anderson, Harry D Bear, Charles E Geyer, Morton S Kahlenberg, André Robidoux, Richard G Margolese, James L Hoehn, Victor G Vogel, Shaker R Dakhil, Deimante Tamkus, Karen M King, Eduardo R Pajon, Mary Johanna Wright, Jean Robert, Soonmyung Paik, Eleftherios P Mamounas, Norman Wolmark, None, Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 Journal of Clinical Oncology. ,vol. 26, pp. 778- 785 ,(2008) , 10.1200/JCO.2007.15.0235

Charles M. Perou, Therese Sørlie, Michael B. Eisen, Matt van de Rijn, Stefanie S. Jeffrey, Christian A. Rees, Jonathan R. Pollack, Douglas T. Ross, Hilde Johnsen, Lars A. Akslen, Øystein Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley X. Zhu, Per E. Lønning, Anne-Lise Børresen-Dale, Patrick O. Brown, David Botstein, Molecular portraits of human breast tumours Nature. ,vol. 406, pp. 747- 752 ,(2000) , 10.1038/35021093

Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler, Lars A Akslen, Joseph Ragaz, Allen M Gown, C Blake Gilks, Matt van de Rijn, Charles M Perou, None, Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Clinical Cancer Research. ,vol. 10, pp. 5367- 5374 ,(2004) , 10.1158/1078-0432.CCR-04-0220

S. Dawood, K. Broglio, F.J. Esteva, W. Yang, S.-W. Kau, R. Islam, C. Albarracin, T.K. Yu, M. Green, G.N. Hortobagyi, A.M. Gonzalez-Angulo, Survival among women with triple receptor-negative breast cancer and brain metastases Annals of Oncology. ,vol. 20, pp. 621- 627 ,(2009) , 10.1093/ANNONC/MDN682